The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype

2015 ◽  
Vol 38 (6) ◽  
pp. 1059-1074 ◽  
Author(s):  
Stefan Kölker ◽  
Vassili Valayannopoulos ◽  
Alberto B. Burlina ◽  
Jolanta Sykut-Cegielska ◽  
Frits A. Wijburg ◽  
...  
2015 ◽  
Vol 38 (6) ◽  
pp. 1157-1158 ◽  
Author(s):  
Stefan Kölker ◽  
Vassili Valayannopoulos ◽  
Alberto B. Burlina ◽  
Jolanta Sykut-Cegielska ◽  
Frits A. Wijburg ◽  
...  

2015 ◽  
Vol 38 (6) ◽  
pp. 1155-1156 ◽  
Author(s):  
Stefan Kölker ◽  
Angeles Garcia Cazorla ◽  
Vassili Valayannopoulos ◽  
Allan M. Lund ◽  
Alberto B. Burlina ◽  
...  

2015 ◽  
Vol 38 (6) ◽  
pp. 1041-1057 ◽  
Author(s):  
Stefan Kölker ◽  
Angeles Garcia Cazorla ◽  
Vassili Valayannopoulos ◽  
Allan M. Lund ◽  
Alberto B. Burlina ◽  
...  

Author(s):  
Stefan Kölker ◽  
◽  
Dries Dobbelaere ◽  
Johannes Häberle ◽  
Peter Burgard ◽  
...  

2019 ◽  
Vol 231 (02) ◽  
pp. 74-79 ◽  
Author(s):  
Dorotea Ninković ◽  
Željka Mustapić ◽  
Dorotea Bartoniček ◽  
Vesna Benjak ◽  
Mario Ćuk ◽  
...  

Abstract Background Hyperammonemic encephalopathy in newborns with urea cycle disorders and certain organic acidurias can cause severe brain injury, coma and death. Standard therapy includes protein restriction, nitrogen-scavenging drugs, prevention of catabolism and hemodialysis. Neuroprotective hypothermia as part of the treatment has been reported only 3 times. It has been suggested that mild systemic hypothermia can contribute to better neurological outcomes in hyperammonemic encephalopathy. However, the limited experience precludes accurate conclusions on safety and efficacy. Methods Whole body therapeutic hypothermia was included in the standard treatment of hyperammonemic encephalopathy in 4 neonates with urea cycle disorder or organic aciduria. Results Two patients survived the initial crisis. One patient has a developmental quotient of 0.8, while the other shows severe developmental delay. The cooling protocol had to be discontinued in 3 patients due to the otherwise untreatable complications (hypotension and hemorrhage). Conclusion The efficacy and safety of therapeutic hypothermia in the treatment of neonatal hyperammonemic encephalopathy depend on various factors, requiring further evaluation.


2016 ◽  
Vol 04 (01) ◽  
pp. 033-043
Author(s):  
Johannes Häberle ◽  
Véronique Rüfenacht

Sign in / Sign up

Export Citation Format

Share Document